GSK Velu’s Neuberg Diagnostics raises funds from Kotak Alternate Asset

Q: How long will it take to read this news story?

The story "GSK Velu’s Neuberg Diagnostics raises funds from Kotak Alternate Asset" has 318 words across 21 sentences, which will take approximately 2 - 3 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "GSK Velu’s Neuberg Diagnostics raises funds from Kotak Alternate Asset" was covered 12 hours ago by YourStory, a news publisher based in India.

Q: How trustworthy is 'YourStory' news outlet?

YourStory is a fully independent (privately-owned) news outlet established in 2008 that covers mostly startups, economy, and business news. The outlet is headquartered in India and publishes an average of 20 news stories per day. It's most recent story was published 10 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #25037108</li><li>URL: https://beamstart.com/news/gsk-velus-neuberg-diagnostics-raises-1736514027380</li></ul>

YourStory Logo YourStory 12h ago

GSK Velu’s Neuberg Diagnostics raises funds from Kotak Alternate Asset - YourStory

Quick Summary:

Kotak Strategic Situations India Fund Il, managed by Kotak Alternate Asset Managers Ltd, has made an investment Rs 940 crore ($109.5 million) in diagnostic chain Neuberg Diagnostics Pvt.Ltd.

Neuberg will use the fresh capital to further its inorganic expansion strategy.

"This funding will enable us to enhance our capabilities in the areas of personalised medicine and integrated diagnostics and inorganically expand our footprint across the country.